These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 27474089)
41. Innate Immune Cytokines, Fibroblast Phenotypes, and Regulation of Extracellular Matrix in Lung. Richards CD J Interferon Cytokine Res; 2017 Feb; 37(2):52-61. PubMed ID: 28117653 [TBL] [Abstract][Full Text] [Related]
42. IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury. Ballinger MN; Newstead MW; Zeng X; Bhan U; Mo XM; Kunkel SL; Moore BB; Flavell R; Christman JW; Standiford TJ J Immunol; 2015 Feb; 194(4):1894-904. PubMed ID: 25595781 [TBL] [Abstract][Full Text] [Related]
43. The Epithelial-Immune Crosstalk in Pulmonary Fibrosis. Planté-Bordeneuve T; Pilette C; Froidure A Front Immunol; 2021; 12():631235. PubMed ID: 34093523 [TBL] [Abstract][Full Text] [Related]
44. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs. Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500 [TBL] [Abstract][Full Text] [Related]
45. Novel Mechanisms for the Antifibrotic Action of Nintedanib. Rangarajan S; Kurundkar A; Kurundkar D; Bernard K; Sanders YY; Ding Q; Antony VB; Zhang J; Zmijewski J; Thannickal VJ Am J Respir Cell Mol Biol; 2016 Jan; 54(1):51-9. PubMed ID: 26072676 [TBL] [Abstract][Full Text] [Related]
46. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions. Xu X; Dai H; Wang C Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066 [TBL] [Abstract][Full Text] [Related]
47. Effects of hypoxia and hyperoxia on the differential expression of VEGF-A isoforms and receptors in Idiopathic Pulmonary Fibrosis (IPF). Barratt SL; Blythe T; Ourradi K; Jarrett C; Welsh GI; Bates DO; Millar AB Respir Res; 2018 Jan; 19(1):9. PubMed ID: 29334947 [TBL] [Abstract][Full Text] [Related]
48. PGC1α repression in IPF fibroblasts drives a pathologic metabolic, secretory and fibrogenic state. Caporarello N; Meridew JA; Jones DL; Tan Q; Haak AJ; Choi KM; Manlove LJ; Prakash YS; Tschumperlin DJ; Ligresti G Thorax; 2019 Aug; 74(8):749-760. PubMed ID: 31182654 [TBL] [Abstract][Full Text] [Related]
49. Essential role for the ATG4B protease and autophagy in bleomycin-induced pulmonary fibrosis. Cabrera S; Maciel M; Herrera I; Nava T; Vergara F; Gaxiola M; López-Otín C; Selman M; Pardo A Autophagy; 2015 Apr; 11(4):670-84. PubMed ID: 25906080 [TBL] [Abstract][Full Text] [Related]
50. Histopathological and molecular analysis of idiopathic pulmonary fibrosis lungs from patients treated with pirfenidone or nintedanib. Zhang Y; Jones KD; Achtar-Zadeh N; Green G; Kukreja J; Xu B; Wolters PJ Histopathology; 2019 Jan; 74(2):341-349. PubMed ID: 30152895 [TBL] [Abstract][Full Text] [Related]
51. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis. Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592 [TBL] [Abstract][Full Text] [Related]
52. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling. Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047 [TBL] [Abstract][Full Text] [Related]
53. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation. Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015 [TBL] [Abstract][Full Text] [Related]